Bullish option flow detected in Bristol Myers (BMY) Squibb with 203,938 calls trading, 22x expected, and implied vol increasing over 5 points to 22.90%. Jan-25 52.5 calls and Jan-25 50 calls are the most active options, with total volume in those strikes near 108,400 contracts. The Put/Call Ratio is 0.02. Earnings are expected on February 6th.
Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on BMY:
- PFE, BMY, SNY, and Others Are Set to Raise Prices on 250 Drugs
- Bristol-Myers Squibb’s Patent Expansion Plan May Run into Regulator Trouble
- Halozyme reports FDA approval for Opdivo co-formulated with Enhanze
- Century Therapeutics price target lowered to $4 from $12 at Piper Sandler
- Bristol Myers announces FDA approval of Opdivo Qvantig injection
Looking for a trading platform? Check out TipRanks' Best Online Brokers , and find the ideal broker for your trades.
Report an Issue